Publications
5600 Results
- Journal / Conference
- Clinical Cancer Research Jul 1;30(13):2709-2718
- Year
- 2024
- Research Committee(s)
- Breast
- PMID
- PMID38640040
- PMC
- PMC11287923
- Study Number(s)
- CTSU/E1Z11
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
- Journal / Conference
- Quality of Life Research Jul 30. doi: 10.1007/s11136-024-03746-5. Online ahead of print
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39080091
Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04
- Journal / Conference
- Journal of the National Cancer Institute Apr 5;116(4):497-505
- Year
- 2024
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID38175791
Interventions addressing health-related social needs among patients with cancer
- Journal / Conference
- Contemporary Clinical Trials Jul:142:107564
- Year
- 2024
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID38704119
- PMC
- PMC11180561
- Study Number(s)
- S1904
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention Jun 13. doi: 10.1158/1055-9965.EPI-24-0096. Online ahead of print
- Year
- 2024
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID38869494
- Study Number(s)
- S0000, SWOG-9217
Genome-wide analysis to assess if heavy alcohol consumption modifies the association between SNPs and pancreatic cancer risk
- Journal / Conference
- Therapeutic Advances in Medical Oncology Apr 29:16:17588359241248336
- Year
- 2024
- Research Committee(s)
- Breast
- PMID
- PMID38686016
- PMC
- PMC11057345
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy
- Journal / Conference
- Oncologist Jun 3;29(6):e843-e847
- Year
- 2024
- Research Committee(s)
- Lung
- PMID
- PMID38597608
- PMC
- PMC11144964
- Study Number(s)
- LUNGMAP
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
- Journal / Conference
- Lancet Oncology Aug;25(8):1038-1052
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID38942046
- PMC
- PMC11323681
- Study Number(s)
- CTSU/EA8143
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
- Journal / Conference
- Journal of Clinical Oncology Jul 1;42(19):2295-2305
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38547438
- Study Number(s)
- CTSU/C80702
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
- Journal / Conference
- Studies in Health Technology and Informatics Aug 22:316:1368-1372
- Year
- 2024
- Research Committee(s)
- Multiple sites